Dendreon may not be sold. Provenge is in my opinion.
1.2 -1.5 Billion $ NOLS remain intact from my understanding. Also Amick (DNDN) may have kept D-3263 which could be worth possibly billions. Figure it out. in my honest opinion.
Interesting Read:
psoralen_uva from yahoo board wrote:
Excluded Assets : What is the value of D-3263 Assets ?
Valeant does not get D-3263 Assets.
Excluded assets include "D-3263 Assets." D-3263 Assets means the following, in each case only to the extent not used in the development, manufacturing, marketing, sale, or distribution of Provenge: i) the investigational new drug application filed with FDA for D-3263, ii) any inventory of D-3263, iii) all pre-clinical and clinical study reports data for D-3263; and iv) the patents and patent application set forth on Schedule 1.2(l).
Page 68 of 65, Doc 355-1, Filed 02/05/15
Shareholders should get some value for this D-3263 Assets.
D-3263 is a TRPM8 agonist ( transient receptor potential melastatin member 8) Less
Back To Board
Disclaimer:
All the above opinions are collected from yahoo message board..just for entertainment purpose. Not telling anyone to buy or sell!
